Durham.

PositionTriangle

DURHAM -- Gaithersburg, Md. based drug developer Cytomedix acquired Aldagen in a deal worth more than $40 million. The biotechnology company will operate as a wholly owned subsidiary and retain its 14 employees and local manufacturing operations. It will also continue to develop its stroke treatment. Three board members, including CEO Lyle...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT